Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope
Open Access
- 6 November 2019
- journal article
- review article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 68 (11) , 1901-1907
Abstract
L-arginine depletion by regulatory cells and cancer cells expressing arginase-1 (Arg-1) is a vital contributor to the immunosuppressive tumor microenvironment in patients with cancer. We have recently described the existence of pro-inflammatory effector T cells that recognize Arg-1. Hence, Arg-1-specific self-reactive T cells are a naturally occurring part of the memory T-cell repertoire of the human immune system. Here, we further characterize a highly immunogenic epitope from Arg-1. We describe frequent T-cell-based immune responses against this epitope in patients with cancer, as well as in healthy donors. Furthermore, we show that Arg-1-specific T cells expand in response to the TH2 cytokine interleukin (IL)-4 without any specific stimulation. Arg-1-specific memory TH1 cells that respond to increased IL-4 concentration may, therefore, drive the immune response back into the TH1 pathway. Arg-1-specific T cells thus appear to have an important function in immune regulation. Because Arg-1 plays an important role in the immunosuppressive microenvironment in most cancers, an immune modulatory vaccination approach can readily be employed to tilt the balance away from immune suppression in these settings.Keywords
Funding Information
- Kræftens Bekæmpelse
- Herlev Hospital
- Innovationsfonden
- IO Biotech ApS
This publication has 28 references indexed in Scilit:
- The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4+T cellsOncoImmunology, 2013
- HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer PatientsCancer Research, 2013
- Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patientsOncoImmunology, 2012
- CD4 responses against IDOOncoImmunology, 2012
- Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulatorsBlood, 2011
- IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancerInternational Journal of Cancer, 2009
- Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated GranulocytesCancer Research, 2009
- Vaccination against the Forkhead Family Transcription Factor Foxp3 Enhances Tumor ImmunityCancer Research, 2007
- l-arginine availability regulates T-lymphocyte cell-cycle progressionBlood, 2006
- l-Arginine modulates CD3ζ expression and T cell function in activated human T lymphocytesCellular Immunology, 2004